Bendamustine in the treatment of patients with indolent non‐Hodgkin lymphoma refractory or relapse to rituximab treatment: An open‐label, single‐agent, multicenter study in China

Bibliographic Details
Title: Bendamustine in the treatment of patients with indolent non‐Hodgkin lymphoma refractory or relapse to rituximab treatment: An open‐label, single‐agent, multicenter study in China
Authors: Gao, Yan, Liu, Yizhen, Wang, Yafei, Zhang, Qingyuan, Wu, Depei, Ye, Xu, Wu, Jianqiu, Xu, Wei, Zhou, Jianfeng, Yang, Yu, Cen, Hong, Zhang, Feng, Xiang, Ying, Tang, Xiaoqiong, Ding, Kaiyang, Lin, JinYing, Ma, Lei, Wang, Shunqing, Yu, Hao, Zhao, Yang, Song, Bin, Lv, Fangfang, Huang, Huiqiang
Source: Cancer. 129(4):551-559
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100171665684.0x000001&indx=1&recIds=ETOCvdc_100171665684.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:0008543X
Published in:Cancer
Language:English